drugset / Trial / NCT03485274
Substance Misuse To Psychiatric Disorders for Cannabis
RandomizedParallel-groupSingle-blindTreatment
Summary
With the recent availability of vortioxetine, and the surging phenomenon of cannabis misuses amongst young abusers, it is a timely opportunity to conduct an early pharmacotherapy intervention study to offer an evidence-based strategy aiming to stop individuals with cannabis use disorders with depressive or anxiety symptoms, to develop into a more chronic disabling dependence or co-morbid state.
Timeline
- Start
- 2018-07-25
- Primary completion
- 2023-02-28
- Completion
- 2023-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Vortioxetine | Unknown | 5 mg | Oral |
| Comparator | Vortioxetine | Unknown | 20 mg | Oral |